{
  "ptid_time": "027_S_5093_2017-04-28",
  "img_path": "/data/qiuhui/data/adni/images/027_S_5093/2017-04-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 23,727 mm³, 15.5% below the reference mean. With a Z-score of -0.35 (36.2th percentile), this represents normal volume ; hippocampal volume measures 6,150 mm³, 13.6% below the reference mean. With a Z-score of -1.24 (10.7th percentile), this represents mild atrophy; whole brain volume measures 1,021,070 mm³, 4.8% above the reference mean. With a Z-score of 0.60 (72.6th percentile), this represents normal volume ; entorhinal cortex volume measures 3,507 mm³, 4.5% below the reference mean. With a Z-score of -0.28 (39.1th percentile), this represents normal volume ; fusiform gyrus volume measures 17,033 mm³, 0.1% above the reference mean. With a Z-score of 0.01 (50.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,430 mm³, 17.0% above the reference mean. With a Z-score of 1.48 (93.0th percentile), this represents mild enlargement. ",
  "text_data": "Age is 73.3 years. Gender is Female. Education: 19 years. MMSE: 30.0. MoCA: 26.0. Logical Memory: 14.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.03 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows mild atrophy (Z-score -1.24, 10.7th percentile), which is a key biomarker for Alzheimer's pathology, while other brain regions are within normal ranges. Cognitive testing (MMSE 30, MoCA 26) suggests intact global cognition but possible subtle executive/memory deficits (MoCA borderline). No APOE4 risk allele or amyloid positivity (AV45 normal) reduces Alzheimer's likelihood.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to hippocampal atrophy but normal amyloid and strong cognitive performance)",
  "timestamp": "2025-07-26T04:07:37.188453"
}